Patents by Inventor Robert Peelle
Robert Peelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Modularized interface and related method for connecting plug-in electric vehicles to the energy grid
Patent number: 8736225Abstract: This invention is directed to a modularized interface for connecting a plug-in electric vehicle to the energy grid. For use with public or semi-public outlets, the modularized interface comprises a module and a smart socket, where the module is integrated within or capable of being connected to, the vehicle's charging interface. The module is normally disabled, but is enabled only after the end user is authenticated, the smart socket and its associated meter have been identified, and the module and the end user's account with the local utility are validated. The module meters the energy consumption, and, when the module is disconnected from the smart socket, indicating termination of the charging session, the metered data is communicated to the utility for updating the end user's account, and the module is disabled. The module is also capable of use with conventional outlets located, for example, in private residences.Type: GrantFiled: November 5, 2008Date of Patent: May 27, 2014Assignee: San Diego Gas & Electronic CompanyInventors: Chris W. Chen, Robert Peelle, Viral Bhalodia, Ken Yu, Gabriel Gavrielides, Terry Mohn, John C. Martin -
MODULARIZED INTERFACE AND RELATED METHOD FOR CONNECTING PLUG-IN ELECTRIC VEHICLES TO THE ENERGY GRID
Publication number: 20100045232Abstract: This invention is directed to a modularized interface for connecting a plug-in electric vehicle to the energy grid. For use with public or semi-public outlets, the modularized interface comprises a module and a smart socket, where the module is integrated within or capable of being connected to, the vehicle's charging interface. The module is normally disabled, but is enabled only after the end user is authenticated, the smart socket and its associated meter have been identified, and the module and the end user's account with the local utility are validated. The module meters the energy consumption, and, when the module is disconnected from the smart socket, indicating termination of the charging session, the metered data is communicated to the utility for updating the end user's account, and the module is disabled. The module is also capable of use with conventional outlets located, for example, in private residences.Type: ApplicationFiled: November 5, 2008Publication date: February 25, 2010Inventors: Chris W. Chen, Robert Peelle, Viral Bhalodia, Ken Yu, Gabriel Gavrielides, Terry Mohn, John C. Martin -
Patent number: 7297482Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: GrantFiled: March 18, 2003Date of Patent: November 20, 2007Assignee: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Patent number: 6936421Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: GrantFiled: June 20, 2002Date of Patent: August 30, 2005Assignee: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Publication number: 20030224412Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: ApplicationFiled: March 18, 2003Publication date: December 4, 2003Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Publication number: 20030143562Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: ApplicationFiled: June 20, 2002Publication date: July 31, 2003Applicant: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Patent number: 6562617Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: GrantFiled: July 27, 2000Date of Patent: May 13, 2003Assignee: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Patent number: 6548249Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: GrantFiled: July 27, 2000Date of Patent: April 15, 2003Assignee: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
-
Patent number: 6548632Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.Type: GrantFiled: October 8, 1999Date of Patent: April 15, 2003Assignee: Rigel Pharmaceuticals, Inc.Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger